Pleural effusion, Pleural cytology, predictive markers, lung cancer, systemic anticancer therapy
lung cancer, Non-small cell lung cancer, NSCLC, Radical radiotherapy, chemoradiotherapy, Durvalumab
Non-small cell lung cancer, surgery, multimodality treatment, feasibility, randomised controlled trial, health-related quality of life